Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
IL-17
Biotech
MoonLake shines brighter as IL-17 drug scores latest phase 2 win
MoonLake has maintained its position as a key player in the race to get an IL-17 inhibitor to market for inflammatory skin conditions.
James Waldron
Nov 6, 2023 8:14am
Acelyrin fails late-phase clinical trial months after $540M IPO
Sep 12, 2023 6:30am
MoonLake's IL-17 drug wins 'meet or beat' trial vs. competition
Jun 26, 2023 11:18am
Lilly bets on IL-17-focused Dice Therapeutics with $2.4B deal
Jun 20, 2023 8:00am
